Cell-Based Assays: World Market Prospects 2013-2023

1
Cell-Based Assays World Market Prospects
2013-2023 

• Bharat Book Bureau

2
Summary

• Cell-based testing for pharma - where are that
  technology and its revenues heading?Find what
  the future holds for cell assay technologies.
  Visiongain's updated report gives you revenue
  predictions to 2023. There you discover sales
  data, RD trends, opportunities and
  prospects. You find the potential of those
  biotechnologies. See forecasted sales at overall
  world market, submarket and national level. Also
  you assess emerging trends and predicted events.
  Many opportunities remain - you discover the
  areas to prosper.Cellular assays form an
  important part of drug discovery and testing.
  With our report, you assess products, services,
  technologies (platforms) and companies in that
  fast-growing field. 

3
Continue

• Forecasts and other analyses show you
  prospects and opportunitiesIn our study you
  find revenue forecasting to 2023, historical
  data, growth rates and market shares. Also, you
  see qualitative analysis (SWOT and STEP),
  business news, outlooks and developmental trends.
  You receive 49 tables, 46 charts and three
  research interviews.Our new study lets you
  investigate the most promising and lucrative
  aspects of cell-based systems. We help you stay
  ahead in knowledge. Reduce the risk of being left
  behind.The following sections show how you
  discover the future of cell-based assaying.

4
Continue

• Find prospects for the world market and
  submarketsAlong with revenue prediction for the
  overall world market, you see forecasts to 2023
  for submarkets Products Services.You also
  find world-level revenue forecasts for these
  allied markets Pharmaceutical RD - global
  spending forecast to 2023 Forecasts of
  biological drug submarkets in 2016.Our
  investigation discusses what stimulates and
  restrains business. You find dynamics of the
  industry and assess its potential sales, seeing
  what's likely to achieve the most success.Find
  where growth can occur. Our work also breaks the
  main world forecast into geographical markets.

5
Continue

• See prospects in leading countriesMedical
  RD worldwide will influence the drug testing
  industry, with rising demand for cell assays in
  developed and developing countries. There exist
  many opportunities.You see individual revenue
  forecasts to 2023 for eleven national markets
  US Japan Germany, France, UK, Italy and Spain
  (EU5) Brazil, Russia, India and China (BRIC
  nations).Our analyses show revenue growth for
  cellular assays will occur in established and
  emerging national markets. Developments from 2013
  will stimulate expansion of that industry and its
  sales.

6
Continue

• You see trends for technological
  developmentOur report lets you investigate
  established and emerging trends for cell
  assaying Lead identification and toxicity
  testing Detection, including label-free
  technology Reporter genes Immortalised cell
  lines Primary cells Stem cells.Our study
  also discusses applications of those cellular
  technologies Target validation Primary
  screening Secondary screening ADME
  screening High throughput screening.Discover
  progress. You assess innovations, hearing about
  progress and finding its significance.For large
  companies and specialty firms there exist many
  opportunities. Our work explains, covering many
  issues.

7
Continue

• What affects the cell assays field?Our
  report discusses trends, issues and events
  affecting that industry, market and environment
  from 2013, looking ahead Product categories -
  equipment, disposables and consumables
  Applications and cellular testing as a share of
  pharma RD spending Strengths and weaknesses of
  that analytical industry and market Use of stem
  cells 3D cell culture - closer to the true
  cellular environment.We also discuss these
  aspects of the field G-protein-coupled
  receptors (GPCRs) Biologics (biological drugs)
  and biosimilars Miniaturisation and automation,
  including microfluidics Multiplexing - making
  assays more efficient High content screening
  (HCS) Outsourcing (off-shoring) of cell-based
  testing.You explore technological, economic and
  political questions, assessing companies,
  competition and outlooks for business. See what
  the future holds.

8
Continue

• Leading companies and 2016 market valueWe
  predict the world market for cell assays will
  reach 4.7bn in 2016, and expand further to
  2023.From 2013, cell-based testing systems will
  gain rising shares of the pharma analytical
  market and achieve high revenues. Cellular
  screening of drugs holds great scope for
  investment, technological advances and commercial
  success.You explore products, services and
  organisations with high potential. Our work
  discusses these leading companies, including
  contract service providers (CROs) Covance
  Pharmaceutical Product Development (PPD)
  Charles River Laboratories BD Biosciences GE
  Healthcare Beckman Coulter DiscoveRx EMD
  Millipore.

9
Continue

• We also discuss these organisations and
  others Evotec Life Technologies
  (Invitrogen) PerkinElmer MD Biosciences
  Sigma-Aldrich Thermo Fisher Scientific
  Fluofarma Marin Biologic Laboratories.From
  2013 to 2023 there will arise many opportunities.
  Our report shows you the technological and
  commercial possibilities, helping you stay ahead.

10
Continue

• Seven main ways Cell-Based Assays World
  Market Prospects 2013-2023 helpsIn particular,
  then, our investigation gives you the following
  knowledge Revenues to 2023 for the overall
  world market and main submarkets - you discover
  that industry's prospects Forecasting to 2023
  for US, Japan, Germany, France, UK, Spain, Italy,
  Brazil, Russia, India and China - you see
  regional and national sales predictions
  Discussions and profiles of leading companies -
  you find products, services, capabilities,
  developments and outlooks Interviews with
  authorities in the industry - you discover
  debates and opinions to help you stay ahead
  Understanding of competition and opportunities -
  you see what affects that industry, learning what
  shapes its future Analysis of what stimulates
  and restrains the market - you assess challenges
  and strengths, helping you compete and gain
  advantages Prospects for established firms and
  those seeking to enter the sector - you explore
  needs, practices and outlooks for success.

11
Continue

• You gain information found nowhere
  elseThat work gives independent analysis. You
  receive business intelligence found only in our
  report, seeing where prospects are most
  rewarding.With our study you are less likely to
  fall behind in knowledge or miss opportunity. See
  how you could benefit your research, analyses and
  decisions, also saving time and getting you
  recognition for insight.Our knowledge costs
  only a tiny fraction of potential profits from
  your understanding and harnessing that market.
  See its growth potential and find what you can
  gain.Ordering now lets you discover predictions
  to 2023, finding information you
  needVisiongain's investigation is for everyone
  needing analysis of drug development
  technologies. You find data, trends and
  potentials. Please order our report now.

12
For More Information You Can Visit-

• http//www.bharatbook.com/healthcare-market-r
  esearch-reports/cell-based-assays-world-market-pro
  spects-2013-2023.html
• Or visit us at
• Bharat Book
  Bureau Phone
  91 22 27810772, 27810773
  Toll Free No for USA/Canada
  1-866-279-8368
  Fax [phone]
  E-mail info_at_bharatbook.com
  Website www.bharatbook.com
  Twitter
  https//twitter.com/BharatBook
  Blog http//www.bharatbook.com/mar
  ket-reports-blog/